Indication
Urinary tract irritation
Urinary tract irritation refers to a clinical state of mucosal inflammation and sensory hyperactivity affecting the lower urinary tract, predominantly the bladder and urethra. Read more about Urinary tract irritation
58 drugs 49 manufacturers
Drugs that treat it
Common Urinary tract irritation therapies.
AZO URINARY PAIN RELIEF (phenazopyridine HCl)
PHENAZOPYRIDINE HCL
PHENAZOPYRIDINE HCL
PHENAZOPYRIDINE HCL
PHENAZOPYRIDINE HCL
FLAVOXATE HCL
FLAVOXATE HCL
URINARY PAIN RELIEF (phenazopyridine HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonUrinary tract irritation refers to a clinical state of mucosal inflammation and sensory hyperactivity affecting the lower urinary tract, predominantly the bladder and urethra.
It arises in diverse patient populations from infectious etiologies such as cystitis or urethritis, as well as noninfectious triggers including urinary calculi, mechanical instrumentation, chemical exposures, or radiation.
Pathophysiologically, disruption of the protective urothelial barrier exposes submucosal afferent nociceptors and induces localized smooth muscle spasm.
This cascade clinically manifests as lower urinary tract symptoms, characteristically dysuria (burning or stinging on micturition), urinary urgency, increased urinary frequency, and suprapubic discomfort.
- bcm.edu
Urinary tract irritation refers to a clinical state of mucosal inflammation and sensory hyperactivity affecting the lower urinary tract, predominantly the bladder and urethra It arises in diverse patient populations from infectious etiologies such as cystitis or urethritis, as well as noninfectious triggers including urinary calculi, mechanical instrumentation, chemical exposures, or radiation
- nih.gov
Urinary tract irritation refers to a clinical state of mucosal inflammation and sensory hyperactivity affecting the lower urinary tract, predominantly the bladder and urethra Pathophysiologically, disruption of the protective urothelial barrier exposes submucosal afferent nociceptors and induces localized smooth muscle spasm
- merckmanuals.com
It arises in diverse patient populations from infectious etiologies such as cystitis or urethritis, as well as noninfectious triggers including urinary calculi, mechanical instrumentation, chemical exposures, or radiation Pathophysiologically, disruption of the protective urothelial barrier exposes submucosal afferent nociceptors and induces localized smooth muscle spasm This cascade clinically manifests as lower urinary tract symptoms, characteristically dysuria (burning or stinging on micturit...
- cdc.gov
This cascade clinically manifests as lower urinary tract symptoms, characteristically dysuria (burning or stinging on micturition), urinary urgency, increased urinary frequency, and suprapubic discomfort
Personalize your experience
Follow Urinary tract irritation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.